Report of Foreign Issuer (6-k)
December 16 2019 - 7:54AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16 OF
THE
SECURITIES EXCHANGE ACT OF 1934
For the month of, December 2019
Commission File Number 001-37652
Midatech Pharma PLC
(Translation of registrant’s name
into English)
Oddfellows House,
19 Newport Road,
Cardiff, CF24 0AA, United Kingdom
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F x Form
40-F o
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(1): o
Indicate by check mark if the registrant is submitting the Form
6-K in paper as permitted by Regulation S-T Rule 101(b)(7): [ ]
SUBMITTED HEREWITH
Attached to the Registrant’s Form 6-K filing for the month
of December 2019, and incorporated by reference herein, is:
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Press release, dated December 16, 2019 entitled
“Receipt of NASDAQ Notice”
|
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly
authorized.
|
Midatech Pharma PLC
|
|
|
|
|
Date: December 16, 2019
|
By:
|
/s/ Stephen Stamp
|
|
|
|
|
|
Stephen Stamp
Chief Financial Officer
|
Exhibit Index
Exhibit No.
|
|
Description
|
|
|
|
99.1
|
|
Press release, dated December 16, 2019 entitled
“Receipt of NASDAQ Notice”
|
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Mar 2024 to Apr 2024
Midatech Pharma (NASDAQ:MTP)
Historical Stock Chart
From Apr 2023 to Apr 2024